JWCA
CVS icon

J.W. Cole Advisors’s CVS Health CVS Stock Holding History

J.W. Cole Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51M Buy
+24,258
New +$2.17M 0.04% 426
2026
Q1 		– Sell
-24,877
Closed -$1.89M – 899
2025
Q4 		$1.89M Sell
24,877
-1,530
-6% -$121K 0.05% 405
2025
Q3 		$1.99M Buy
26,407
+1,852
+8% +$127K 0.04% 453
2025
Q2 		$1.69M Buy
24,555
+1,266
+5% +$83K 0.04% 479
2025
Q1 		$1.58M Buy
+23,289
New +$1.39M 0.05% 383
2024
Q4 		– Sell
-6,671
Closed -$419K – 966
2024
Q3 		$419K Sell
6,671
-370
-5% -$21.6K 0.02% 663
2024
Q2 		$416K Sell
7,041
-5,482
-44% -$343K 0.02% 578
2024
Q1 		$999K Sell
12,523
-5,744
-31% -$439K 0.05% 342
2023
Q4 		$1.44M Buy
18,267
+546
+3% +$38.9K 0.08% 242
2023
Q3 		$1.24M Sell
17,721
-2,351
-12% -$167K 0.09% 222
2023
Q2 		$1.39M Sell
20,072
-1,333
-6% -$94.8K 0.1% 218
2023
Q1 		$1.59M Sell
21,405
-7,524
-26% -$631K 0.11% 209
2022
Q4 		$2.7M Sell
28,929
-837
-3% -$80.8K 0.21% 125
2022
Q3 		$2.84M Buy
29,766
+271
+0.9% +$26.8K 0.24% 106
2022
Q2 		$2.73M Sell
29,495
-3,019
-9% -$295K 0.22% 116
2022
Q1 		$3.29M Sell
32,514
-3,492
-10% -$367K 0.22% 113
2021
Q4 		$3.71M Sell
36,006
-319
-0.9% -$29.5K 0.24% 93
2021
Q3 		$3.08M Buy
36,325
+4,816
+15% +$403K 0.22% 73
2021
Q2 		$2.63M Sell
31,509
-6,192
-16% -$507K 0.21% 114
2021
Q1 		$2.84M Buy
37,701
+1,623
+4% +$118K 0.27% 85
2020
Q4 		$2.46M Buy
36,078
+886
+3% +$57.6K 0.26% 96
2020
Q3 		$2.06M Buy
35,192
+13,703
+64% +$853K 0.16% 149
2020
Q2 		$1.4M Buy
+21,489
New +$1.35M 0.21% 125
2020
Q1 		– Sell
-17,397
Closed -$1.29M – 177
2019
Q4 		$1.29M Buy
+17,397
New +$1.22M 0.16% 155

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

J.W. Cole Advisors's CVS Position: Q2 2026 in Review

J.W. Cole Advisors opened a new position in CVS Health (CVS) in Q2 2026: 24,258 shares worth $2.51M. The stake represents 0.04% of the portfolio and ranks #426 among its holdings. This is a return to the name: J.W. Cole Advisors previously reported a position in CVS as recently as Q4 2025.

J.W. Cole Advisors first reported a position in CVS in Q4 2019 and has held it in 24 quarters since. The position peaked at $3.71M in Q4 2021. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • J.W. Cole Advisors held 24,258 shares of CVS Health worth $2.51M as of Q2 2026.
  • CVS Health was a new J.W. Cole Advisors position in Q2 2026.
  • CVS Health made up 0.04% of J.W. Cole Advisors's portfolio in Q2 2026, its #426 holding.
  • J.W. Cole Advisors first reported a position in CVS Health in Q4 2019 and has held it in 24 quarters since.
  • J.W. Cole Advisors's CVS Health position peaked at $3.71M in Q4 2021.
  • 650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.